When navigating the intricacies of nanomedicine development, a CDMO partner with Ardena’s experience can have a profound impact. Our integrated nanomedicine services handle every aspect of your project from start to finish, providing comprehensive solutions to any issues.
Here is what sets Ardena apart as your ideal nanomedicine partner:
Seamless integration of services
You benefit from a seamless integration of services on one multidisciplinary platform. From payload and API services to nanomedicine manufacturing and clinical packaging, we provide a unified approach that mitigates risks and accelerates your project timeline.
- API services: We seamlessly integrate payload procurement with the development and manufacturing of small molecule APIs, ensuring optimal compatibility for nanoparticle formulations.
- Custom building blocks: We specialize in producing custom lipids, monomers, polymer micelles and inorganic complexes, providing essential building blocks for tailored nanomedicine solutions.
- Nanomedicine development: Through leveraging cutting-edge techniques, we offer comprehensive nanomedicine services, including technology transfer, analytical, process and scale-up development for efficient and cGMP-compliant production processes.
- Nanomedicine manufacturing: Our state-of-the-art facilities are equipped for scaling up nanoparticle production, adhering to cGMP standards to deliver reliable and consistent bulk drug products.
- Fill and finish, clinical packaging and logistics: Tailored to meet stringent timelines and study designs, our services include aseptic fill and finish, clinical packaging and logistics, ensuring the reliable delivery of GMP-compliant materials to trial sites.
- Regulatory support: With expertise in CMC documentation, regulatory navigation and strategic advice, we expedite global product approval and ensure compliance with regulatory guidelines.
- Bioanalysis services: Our precise bioanalytical measurements support timely milestone achievements and regulatory submissions for nanoparticle-based formulations.
